monoclonal Latest News

Biosimilars for recombinant human insulin and insulin glargine

Consider novel linker strategy techniques to increase efficacy of ADC products

Frost & Sullivan hosts complimentary webinar discussing the potential benefits and risks of an untapped market

A new report by Visiongain predicts that overall revenues for monoclonal antibody (mAb) therapies will rise between 2011 and 2021. The world mAb drugs market will reach $62.3bn in 2015, up from revenues of $44.6bn (USD) in 2010.

New Healthcare market report from Datamonitor: "R&D Trends: HIV - An active pipeline faces fierce competition in the HIV market"

According to our new research report 'Global Monoclonal Antibody Market Analysis', the global monoclonal antibodies market witnessed an annual growth rate of around 13% during 2008-2009.

Although the therapeutic vaccine market has experienced a range of setbacks and disappointments, technological evolution should ultimately enable therapeutic vaccines to make similar commercial breakthroughs as monoclonal antibodies, notes Kalorama.

Bharatbook added a new report on "Therapeutic Monoclonal Antibodies: World Market 2010-2025" which gives the potential applications and prospects on worldwide Therapeutic Monoclonal Antibodies.

The global market for diagnostic and therapeutic market is expected to exceed $ 25 million market by the end of 2010. mAbs held the top 3 ranks among the top selling brands in 2008.

Randox Life Sciences is a recognised primary manufacturer of high quality, cost effective monoclonal antibodies to both classic and novel targets.

MedImmune has agreed to license the rights to develop Trellis Bioscience's monoclonal antibody products for the treatment of respiratory syncytial virus (RSV).

Lab901 to present their Protein ScreenTape(R) platform

New Pharmaceuticals research report from Business Insights is now available from Fast Market Research

Recently published research from Business Insights, "Preclinical Development of Monoclonal Antibodies and Related Biologicals: Emerging technologies and new therapeutic candidates", is now available at Fast Market Research

Monoclonal antibody-based therapies for cancer are a thriving part of the biotechnology sector, as our new market report explains.